Liver diseases are fast emerging as global health priorities. Fatty liver is described in the
setting of non-alcoholic fatty liver disease (NAFLD) as well as alcoholic liver disease (ALD) …

One of the most common chronic liver disorders, affecting mainly people in Western
countries, is nonalcoholic fatty liver disease (NAFLD). Unfortunately, its pathophysiological …

The conventional paradigm of nonalcoholic fatty liver disease representing the “hepatic
manifestation of the metabolic syndrome” is outdated. We identified and summarized …

Nonalcoholic Fatty Liver Disease (NAFLD) represents the leading cause of liver disease in
developed countries but its diffusion is currently also emerging in Asian countries, in South …

Nonalcoholic fatty liver disease (NAFLD) refers to a group of conditions characterized by
hepatic steatosis in the absence of significant alcohol consumption. NAFLD is seen …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Metabolic syndrome (MetS) is a disease composed of different risk factors such as obesity,
type 2 diabetes or dyslipidemia. The prevalence of this syndrome is increasing worldwide in …

Objectives: Non-alcoholic fatty liver disease (NAFLD) is closely linked to obesity; however, 5–
8% of lean subjects also have evidence of NAFLD. We aimed to investigate clinical, genetic …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease,
encompassing a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis …

Excessive accumulation of triglycerides (TG) in liver, in the absence of significant alcohol
consumption is nonalcoholic fatty liver disease (NAFLD). NAFLD is a significant risk factor …